Skip to content
value.today
Adventa Berhad logo

Adventa Berhad

7191.KL
$25 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Adventa Berhad in brief

Adventa Berhad is a listed company in the Healthcare sector, based in Malaysia. It was founded in 2004. Its last known market value was $25 M (January 2024); there is no current figure. Its shares trade under the symbol 7191.KL (Malaysia).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Adventa Berhad

Adventa Berhad (MYX: 7191) is a Malaysian holding company. It is headquartered in Petaling Jaya, Selangor, and is part of the Management of Companies and Enterprises Industry. It was founded in 2004. Adventa initially invested in the glove-making business. In 2012, the group divested the glove business to Aspion. The group then acquired Electron Beam and Lucenxia, which led them into the health care businesses. Their business also includes distribution and third-party logistics (3PL) for other health care companies.

In 2013, the group signed a partnership with Crawford Healthcare Limited, a United Kingdom healthcare company, to distribute the wound care products, Kerra™. The firm set up a new online portal, MyCare, selling healthcare and beauty products.

In 2014, the company will start its home renal dialysis service, which is known as the company's flagship business.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Adventa Berhad timeline

1 events, 2004
  1. 2004
  2. 🏁
    · approximate
    Founded

Events of Adventa Berhad from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$10 M$21 M$31 M$41 M20232024

World rank over time

▼ down 464 places since 2022
2022-01-07: #27511#27,51120222023-07-30: #30095#30,09520232024-01-05: #27975#27,9752024

Rank in Malaysia: #157 (Jan 2022) · #302 (Jul 2023) · #302 (Jan 2024)

CompanyMarket capP/ENet marginRev. growth
Adventa Berhad🇲🇾$25 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from Wikidata, value.today research, Wikipedia.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Adventa Berhad? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Adventa Berhad's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Adventa Berhad? Suggest a correction